Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR13C3 Inhibitors

OR13C3 inhibitors are a distinct class of chemical compounds designed to selectively target the OR13C3 receptor, a member of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors, including OR13C3, are primarily known for their role in detecting odor molecules, which is fundamental to the sense of smell. However, like many other olfactory receptors, OR13C3 is also expressed in various non-olfactory tissues, suggesting that it may have additional roles in diverse biological processes beyond olfaction. OR13C3 inhibitors function by binding to this receptor, thereby blocking or modulating its ability to interact with natural ligands. This inhibition can lead to alterations in the receptor's signaling pathways, potentially impacting a range of physiological functions. The study of OR13C3 inhibitors is crucial for understanding the broader biological roles of this receptor, particularly in contexts where its function is not yet fully understood. The chemical characteristics of OR13C3 inhibitors are diverse, encompassing a variety of structural classes and mechanisms of action. Some OR13C3 inhibitors act as competitive antagonists, binding directly to the receptor's active site and preventing natural ligands from activating the receptor and initiating signal transduction. This competitive binding effectively blocks the receptor's normal signaling capabilities. Other inhibitors may function allosterically, binding to different sites on the receptor and inducing conformational changes that either reduce its activity or alter its signaling behavior. The development of OR13C3 inhibitors typically involves advanced structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and molecular modeling, to identify critical binding sites on the receptor and optimize the interactions between the inhibitors and OR13C3. Researchers aim to create inhibitors that are highly selective for OR13C3, ensuring minimal off-target effects on other GPCRs or unrelated proteins. Through the study of OR13C3 inhibitors, scientists can gain deeper insights into the receptor's role in various biological systems and explore how its modulation can influence specific cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

An inhibitor of Gi/o proteins that can prevent GPCR-mediated inhibition of adenylate cyclase, possibly influencing OR13C3 signaling if coupled to Gi/o proteins.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

A Cdc42 GTPase inhibitor that can affect cytoskeletal organization and might impact the intracellular trafficking or localization of OR13C3.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

A protein kinase C inhibitor that can modulate phosphorylation events and might alter OR13C3 receptor desensitization or internalization.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

A P2X purinergic antagonist that can affect ATP-mediated cellular signaling, potentially altering downstream pathways that OR13C3 may engage in.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

A calcium chelator that can decrease intracellular calcium levels, possibly affecting calcium-dependent processes involving OR13C3.

Clozapine

5786-21-0sc-200402
sc-200402A
50 mg
500 mg
$68.00
$357.00
11
(1)

An antipsychotic known to antagonize several GPCRs, which could indirectly influence OR13C3

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor that can modulate cytoskeletal dynamics, potentially affecting the trafficking or cell-surface expression of OR13C3.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that can alter PI3K/AKT signaling, potentially affecting OR13C3 function if linked to this pathway.